Abbott LaboratoriesABTNYSE
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+10.2%
5Y CAGR-9.9%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
+10.2%/yr
vs +123.9%/yr prior
5Y CAGR
-9.9%/yr
Recent acceleration
Acceleration
-113.8pp
Decelerating
Percentile
P82
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.01% |
| Q3 2025 | 0.22% |
| Q2 2025 | 3.13% |
| Q1 2025 | 0.04% |
| Q4 2024 | 9.49% |
| Q3 2024 | 1.83% |
| Q2 2024 | 0.76% |
| Q1 2024 | -1.02% |
| Q4 2023 | 1.56% |
| Q3 2023 | -1.72% |
| Q2 2023 | -0.60% |
| Q1 2023 | -0.87% |
| Q4 2022 | 2.25% |
| Q3 2022 | -1.89% |
| Q2 2022 | 0.26% |
| Q1 2022 | -1.58% |
| Q4 2021 | 1.90% |
| Q3 2021 | 0.72% |
| Q2 2021 | 0.66% |
| Q1 2021 | 0.33% |
| Q4 2020 | 5.08% |
| Q3 2020 | 0.39% |
| Q2 2020 | 2.99% |
| Q1 2020 | -1.64% |
| Q4 2019 | -0.95% |
| Q3 2019 | 0.16% |
| Q2 2019 | 1.21% |
| Q1 2019 | 0.65% |
| Q4 2018 | -6.23% |
| Q3 2018 | 4.71% |
| Q2 2018 | -3.52% |
| Q1 2018 | -7.01% |
| Q4 2017 | 5.54% |
| Q3 2017 | 1.54% |
| Q2 2017 | 0.37% |
| Q1 2017 | 28.86% |
| Q4 2016 | 39.28% |
| Q3 2016 | -0.84% |
| Q2 2016 | 0.49% |
| Q1 2016 | -3.90% |